BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34747459)

  • 1. CCR2- and CCR5-mediated macrophage infiltration contributes to glomerular endocapillary hypercellularity in antibody-induced lupus nephritis.
    Zoshima T; Baba T; Tanabe Y; Ishida Y; Nakatani K; Nagata M; Mukaida N; Kawano M
    Rheumatology (Oxford); 2022 Jul; 61(7):3033-3048. PubMed ID: 34747459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models.
    Nakatani K; Fujii H; Hasegawa H; Terada M; Arita N; Ito MR; Ono M; Takahashi S; Saiga K; Yoshimoto S; Iwano M; Shiiki H; Saito Y; Nose M
    Kidney Int; 2004 Apr; 65(4):1290-300. PubMed ID: 15086468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models.
    Nakatani K; Yoshimoto S; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Hasegawa H; Nose M; Saito Y
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F207-16. PubMed ID: 20410215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
    Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
    Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of osteopontin expression in renal tubuli is independent of a histopathological type of glomerular lesions in mouse lupus nephritis.
    Sasaki Y; Yamamoto Y; Miyazaki T; Ito MR; Nose M; Watanabe M
    Pathol Int; 2006 Mar; 56(3):135-43. PubMed ID: 16497246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
    Anders HJ; Belemezova E; Eis V; Segerer S; Vielhauer V; Perez de Lema G; Kretzler M; Cohen CD; Frink M; Horuk R; Hudkins KL; Alpers CE; Mampaso F; Schlöndorff D
    J Am Soc Nephrol; 2004 Jun; 15(6):1504-13. PubMed ID: 15153561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Glomerular CD68+ Cells as a Surrogate Marker for Endocapillary Hypercellularity in Lupus Nephritis.
    Bos EMJ; Sangle SR; Wilhelmus S; Wolterbeek R; Jordan N; D'Cruz D; Isenberg D; Cook HT; Bruijn JA; Bajema IM
    Kidney Int Rep; 2022 Apr; 7(4):841-847. PubMed ID: 35497794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role for CCR5 in murine lupus nephritis.
    Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U
    Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1503-15. PubMed ID: 22442210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
    Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension.
    Abid S; Marcos E; Parpaleix A; Amsellem V; Breau M; Houssaini A; Vienney N; Lefevre M; Derumeaux G; Evans S; Hubeau C; Delcroix M; Quarck R; Adnot S; Lipskaia L
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31320454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.
    Lema GP; Maier H; Nieto E; Vielhauer V; Luckow B; Mampaso F; Schlöndorff D
    J Am Soc Nephrol; 2001 Jul; 12(7):1369-1382. PubMed ID: 11423566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases.
    Furuichi K; Wada T; Sakai N; Iwata Y; Yoshimoto K; Shimizu M; Kobayashi K; Takasawa K; Kida H; Takeda SI; Mukaida N; Matsushima K; Yokoyama H
    Am J Nephrol; 2000; 20(4):291-9. PubMed ID: 10970982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between E-selectin expression and histopathological modification of glomerular lesions by non-nephritogenic IgM antibodies in experimental lupus nephritis.
    Nakatani K; Asai O; Sakan H; Yoshimoto S; Terada M; Nose M; Iwano M; Konishi N
    Mod Rheumatol; 2014 Sep; 24(5):808-15. PubMed ID: 24372297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis.
    Arai M; Ikawa Y; Chujo S; Hamaguchi Y; Ishida W; Shirasaki F; Hasegawa M; Mukaida N; Fujimoto M; Takehara K
    J Dermatol Sci; 2013 Mar; 69(3):250-8. PubMed ID: 23142052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion.
    Bartneck M; Koppe C; Fech V; Warzecha KT; Kohlhepp M; Huss S; Weiskirchen R; Trautwein C; Luedde T; Tacke F
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):327-347. PubMed ID: 32896623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse.
    Itoh J; Nose M; Takahashi S; Ono M; Terasaki S; Kondoh E; Kyogoku M
    Am J Pathol; 1993 Nov; 143(5):1436-43. PubMed ID: 8238259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
    Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
    J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse.
    Takahashi S; Itoh J; Nose M; Ono M; Yamamoto T; Kyogoku M
    Mol Immunol; 1993 Feb; 30(2):177-82. PubMed ID: 8429833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.